Abishai Bijou MathewJourney of Cancer through Psycho Oncology | 4baseCareThe World Health Organization (WHO) estimates that by 2030 cancer incidence will increase by 40% in high-income countries and more than 80%…May 23, 2022May 23, 2022
Abishai Bijou MathewPsychological Distress experienced by Cancer patients — Depression and Anxiety | 4baseCareDistress: The 6th vital sign in Cancer is experienced by a majority (60.3%) of cancer patients ranging from moderate to high level (1)…May 23, 2022May 23, 2022
Abishai Bijou MathewLung Cancer Fighting Foods — Cancer vs Phytochemicals | 4baseCareLung cancer is one of the most common types of cancer that accounts for over 1.80 million deaths in 2020. According to WHO, one-third of…May 23, 2022May 23, 2022
Abishai Bijou MathewDifferent Subtypes of Kidney cancer — Exploring treatment landscape with Precision Oncology |…Kidney cancer: In the era of precision oncology Kidney cancer is a heterogeneous group of cancers with different histologic subtypes…May 20, 2022May 20, 2022
Abishai Bijou MathewRevolutionizing Kidney Cancer with Immunotherapy | 4baseCareKidney cancer is the third urological and sixth most diagnosed cancer in men and eight in women. The prognosis of kidney cancer is poor…May 20, 2022May 20, 2022
Abishai Bijou MathewA Paradigm shift in Kidney Cancer Management | 4baseCareKidney cancer is a heterogeneous group of cancers as it involves different cell types. Most of kidney cancers develop in renal tubules…May 20, 2022May 20, 2022
Abishai Bijou MathewFirst-Line Treatment for Kidney Cancer with CGP | 4baseCareKidney cancer is mainly of two type i.e., Renal cell carcinoma (RCC) and Renal pelvis carcinoma. RCC is the most common subtype of adult…May 20, 2022May 20, 2022
Abishai Bijou MathewAdvancing Immunotherapy in Oncology | 4baseCareCancer is a disease characterized by uncontrolled growth of cells due to genetic mutations and epigenetic modifications that result in…May 20, 2022May 20, 2022
Abishai Bijou MathewTreating triple-negative breast cancer (TNBC) in the era of precision oncology | 4baseCareTriple-negative breast cancer (TNBC) accounts for approximately 15–20% of all breast carcinomas and is associated with earlier age of…Mar 17, 2022Mar 17, 2022
Abishai Bijou MathewTreating Thyroid Cancer with Precision OncologyThyroid cancer is a rare but serious disease and is the most common endocrine malignancy. Every year, more than 567,000 new cases of…Mar 17, 2022Mar 17, 2022
